Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found for Oncology in London, UK

Sort by:
Showing 1 - 10 of 100+ results
Oncology
Recommended by 1 specialist
27 years of experience
Breast Cancer, Clinical Oncology, Medical Oncology

Dr. Shiroma De Silva-Minor is a Consultant Clinical Oncologist at The Oxford University Hospitals NHS Trust, having been appointed in 2008. Her special interest lies in the management of breast cancers.

Dr. De Silva-Minor graduated from University of Wales College of Medicine, Cardiff in 1995 and became a Member of the Royal College of Physicians (UK) in 1999. She then went on to train in her chosen specialty in Clinical Oncology, she trained as a specialist registrar in London, working at nationally renowned cancer centres including UCL The Middlesex Hospital, The Royal Free and The Royal Marsden Hospital. In 2003, Shiroma became a Fellow of the Royal College of Radiologists (UK) in 2003.

During a fellowship in Head and Neck Radiation Oncology at the prestigious Princess Margaret Hospital, Toronto, Shiroma was awarded the Prize for Academic Excellence by the institution and The University of Toronto for her research into the use of PET CT for identifying head and neck tumours for radiotherapy treatment; showing her excellence in the field of research as well as in her practice.

Dr. De Silva-Minor has presented her research at international conferences including The Annual meeting of the Canadian Association of Radiation Oncologists (CARO) in British Columbia and the American Society for Therapeutic Radiology and Oncology (ASTRO) in Colorado and in Philadelphia and at the European Society of Therapeutic Radiation and Oncology (ESTRO).

As a Clinical Oncologist, Dr. De Silva-Minor oversees the whole non-surgical aspect of a patients journey from genetic testing, counselling; through to treatments including chemotherapy, external beam radiotherapy (including partial breast treatment), Intraoperative radiotherapy, PARP inhibitors, CDK4/6 inhibitors and clinical trials; creating the best possible outcomes for patients

Diseases, Medical Tests and Treatments

  • Radiotherapy
  • Chemotherapy
  • Clinical Trials
  • Intraoperative radiotherapy
  • External beam radiotherapy
  • PARP inhibitors
  • CDK4/6 inhibitor
  • Breast Oncology
Read more
Oncology
Offers video consultation
Recommended by 1 specialist
39 years of experience
Prostate Cancer, Clinical Oncology, Medical Oncology

Professor Heather Payne, Consultant Clinical Oncologist, is currently working within the University College London Hospitals NHS Trust, she also sees patients in a private capacity at The Harley Street Clinic and The Prostate Centre. She is highly specialised in the treatment of urological and prostate cancers.

Professor Heather Payne qualified in medicine from St Mary’s Hospital and focused on general medicine after her graduation working in both London and Haiti. After her time abroad she returned to London, where she trained in clinical oncology, and established her interest in urological oncology.

Miss Payne is also an active researcher, where she developed a new treatment plan of high-dose-rate brachytherapy for prostate cancer. Her current research focuses on hormone therapy, sensitisation of hormones and radiotherapy, predictive indices for bowel toxicity with radiotherapy, and treatment and decision making in prostate cancer. She has held the position of Principal Investigator in several high-profile clinical studies and has a significant publication history. Furthermore, She holds the position of chair for the National Prostate Cancer Audit and is on the advisory board for the Prostate Cancer Advisory Group for the UK. 

Read more
Oncology
Offers video consultation
Recommended by 3 specialists
19 years of experience
Bowel Cancer, Colorectal Cancer, Bile Duct Cancer (Cholangiocarcinoma) + 10 more

Dr Daniel Krell is a Consultant Oncologist, specialising in colon, upper GI, lower GI and hepatobiliary cancers and neuroendocrine tumours. 

He has expertise in the use of chemotherapy, targeted therapy and immunotherapy. Dr Krell is also the clinical lead for the management of patients with cancer of unknown primary. He is a member of the multidisciplinary team for gastro-oesophageal and hepatobiliary cancer at the Royal Free London NHS Foundation Trust. He also holds the position of Clinical Lead for Neuroendocrine Tumour Oncology at The Royal Free Hospital.

Dr Krell completed his medical degree at the University of Leeds in 2003. He later completed his specialist training in oncology at University College London and the Royal Free Hospital. He also holds a DPhil in Clinical Medicine gained from the University of Oxford's Wellcome Trust Centre for Human Genetics, funded by Cancer Research UK and HCA.

Dr Krell remains actively involved in clinical research and trials designed to find new cancer therapies for hepatobiliary, gastrointestinal and neuroendocrine tumours. He has published papers in peer-reviewed journals and has presented his work at both national and international conferences and meetings.

Read more
Oncology
Recommended by 2 specialists
21 years of experience
Bowel Cancer, Anal Cancer, Colorectal Cancer + 5 more

Dr. Asad Qureshi is a Consultant Clinical Oncologist with many years of experience in the treatment of gastro-intestinal cancer, including oesophageal cancer, stomach cancer, colon cancer, rectal cancer, and anal cancer.

Dr. Qureshi earned his primary medical qualification at St Bartholomew's and The Royal London Hospital Medical School in 1995. Dr Qureshi then went on to undertake his specialist clinical oncology training at various renowned London hospitals Charing Cross Hospital, St Barts Hospital, Guy’s and St Thomas, and the The Royal Marsden. During this time, Dr Qureshi also completed a research degree in imagining sciences at King's College London evaluating novel radiotherapy techniques in the treatment of lung cancer. Upon completion of his training, Dr Qureshi was appointed Consultant at Guy’s and St Thomas Hospital in 2014, where he had a key role in the opening of the new Cancer Centre and has held senior management positions.

Dr Qureshi is also an active member of the scientific research community and has a keen interest in stereotactic and image-guided radiotherapy, for which he has written a number of peer-reviewed research articles. He is currently the principal investigator for various cancer clinical trials and is also an active member of the medical education community, being a clinical supervisor for clinical oncology junior doctors .

Read more
Oncology
Recommended by 2 specialists
27 years of experience
Clinical Oncology, Medical Oncology

Dr Gaya qualified at St George’s (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London. He was a consultant clinical oncologist at Guy's and St Thomas' Hospitals for 15 years. He now works solely in the private sector

Dr Gaya treats all gastrointestinal tumours (e.g. oesophagus, stomach, liver, pancreas, colon, rectum, anus) using chemotherapy, radiotherapy, immunotherapy, biological therapies, and data from tumour genome analysis. Dr Gaya’s main interests are in the areas of functional cancer imaging (Kings College, London), and combining immunotherapy with radiation treatment.

He is heavily involved with the implementation and usage of the latest radiotherapy techniques such as MRI guided radiotherapy (MRIdian - https://www.genesiscare.com/uk/mrl-hcp/), proton therapy and stereotactic body radiosurgery (gamma knife, cyberknife). He has published and peer-reviewed widely for international journals (https://www.ncbi.nlm.nih.gov/pubmed/?term=Gaya+A). He is an active member of ASTRO (https://www.astro.org/), the Radiosurgery Society (http://therss.org/) and the International Stereotactic Radiosurgery Society (http://www.isrsy.org/en/). Dr Gaya is also interested in the introduction of advanced technology such as AI and machine learning to medicine and is a big supporter of Exponential Medicine (https://exponential.singularityu.org/medicine/) and the Singularity University programs.

Offering both drug-based and radiation-based therapies and close liaison with surgical and interventional radiology, he is a leading authority on the unique combination of multiple treatment modalities and personalised tumour molecular profiling into a treatment package for each patient.

Read more
Oncology
Recommended by 2 specialists
24 years of experience
Prostate Cancer, Bladder Cancer, Brain Cancer + 2 more

Dr Richard Shaffer is a recognised Consultant Clinical Oncologist and a prominent UK expert in the use of radiotherapy for treating benign disease (including Dupuytren’s disease, Ledderhose, plantar fasciitis and keloid scarring) and non-melanoma skin  cancer.

Since starting his practice in 2011, Dr Shaffer has treated approximately 2000 non-cancer (benign) patients with radiotherapy, and provided training and mentoring to fellow consultants starting benign radiotherapy practices. He co-wrote the 2015 Royal College of Radiologists guidelines for radiotherapy for benign conditions and is the founder and President of the International Society for Radiotherapy for Benign Conditions.

He is UK Clinical Lead for Radiotherapy for benign conditions at GenesisCare and chairs the weekly UK skin and benign Multidisciplinary team meeting. He is also Medical Director of XStrahl Limited – a medical device company that makes superficial radiotherapy machines for the treatment of benign conditions and skin cancer.

He has previously been chair of the IMRT-IGRT Radiotherapy Group, the Network Brain Tumour Working Group, Clinical Lead for Radiotherapy at St Luke’s Cancer Centre, and a trustee of the Fountain Centre (a local patient support charity).

In his early career, Dr Shaffer trained as a specialist registrar at various London teaching hospitals and completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada.

Clinical interests

  • Dupuytren’s disease
  • Ledderhose disease
  • Plantar fasciitis
  • Achilles tendinopathy
  • Keloid scarring
  • Skin Cancer
  • Prostate Cancer
  • Bladder Cancer
Read more
Oncology
24 years of experience
Lung Cancer, Medical Oncology, Mesothelioma + 1 more

Dr Thomas Newsom-Davis, Consultant Oncologist, currently works within the Chelsea and Westminster Hospital in London and sees patients privately in clinics across London. He is highly specialised in the treatment and diagnosis of thoracic malignancies, specifically mesothelioma and different cancers of the lung.

Dr Newsom-Davis began his medical education at University College London and Middlesex School of Medicine, graduating in 1998 with a Bachelors in Medicine and Surgery. Following this, he underwent specialist training in medical oncology at Charing Cross and Hammersmith Hospitals. During his training, he also undertook a research degree focusing on tumour immunology, he was awarded a PhD for his work in this field. Following his training, he was appointed to the role of Consultant at Chelsea & Westminster Hospital in 2010.

Currently, Dr Newsom-Davis is the Lead for the Lung Cancer Service at his current NHS hospital. He is also the Vice-Chair of the British Thoracic Oncology Group Committee, which is responsible for the education of medical professionals working in thoracic oncology across the United Kingdom. Moreover, he holds the position of Chair of the Harley Street Clinic Lung Cancer MDT and the HCA Healthcare UK Thoracic Oncology Board.

Dr Newsom-Davis is also an active member of the research community, with a very active clinical trial portfolio and regular invites to present his work at conferences globally. He actively engages with teaching lecturing for numerous professional organisations including the Royal College of Physicians, the European Society of Medical Oncology, the International Association for the Study of Lung Cancer, the British Medical Association, and the Association of Cancer Physicians.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Oncology
22 years of experience
Clinical Oncology, Brain Cancer, Medical Oncology + 1 more

Dr Nicola Rosenfelder is a GMC-Registered Consultant Clinical Oncologist from London, UK, and her NHS practice is based at The Royal Marsden Hospital, London.

She is a neuro-oncologist, specialising in the treatment of brain metastases and benign intracranial and skull base tumours using stereotactic radiosurgery (using linac, cyberknife and gamma knife platforms) and in the use of stereotactic fractionated radiotherapy to deliver high-precision radiation treatment.

Dr Rosenfelder graduated from The University of London in 2000 and undertook her oncology training at The Royal Marsden Hospital and Guy’s and St Thomas’ Hospitals.

During this time she completed an MSc in Oncology, assessing the use of novel methods to improve the accuracy of stereotactic intracranial radiotherapy. She went on to complete an MD in which she set up and ran 2 clinical trials which demonstrated how the accuracy of prostate and cranial radiotherapy could be improved using image-guided radiotherapy for the treatment of prostate cancer and benign intracranial tumours.  She combined her clinical research with lab-based study in Professor Harrington's laboratory at The Institute of Cancer Research where she worked on assessment of the use of oncolytic viruses in augmenting the treatment of prostate cancer, using the virus to deliver further tumoricidal treatments directly to the cancer cells.  She was a Consultant Clinical Oncologist at The Royal Free Hospital before moving back to The Royal Marsden Hospital in 2018. She is the Principal Investigator for the ROAM study at The Royal Marsden and will be opening the SAFER study investigating outcomes in patients undergoing stereotactic radiosurgery for brain metastases.

Her peer-reviewed publications include:

Seizures in patients with brain metastases: A literature review.  Reverberi C, Rees J, Welsh L, Brewer M, Creak A, Solda F, Rosenfelder N. American Journal of
Biomedical Science & Research 2021. ISSN: 2642-1747

Integrated treatment of brain metastases. Rosenfelder N, Brada M.  Curr Opin Oncol. 2019 Nov;31(6):501-50

Breast cancer brain metastases – A 12 year review of treatment outcomes.  De Ieso PB, Schick U, Rosenfelder N, Mohammed K, Ross GM. Breast, 2015;24(4):426-33.

Achieving the relocation accuracy of stereotactic frame-based cranial radiotherapy in a 3-point thermoplastic shell. Rosenfelder NA, Corsini L, McNair H, Pennert K, Burke K, Lamb CM, Aitken A, Ashley S, Khoo V, Brada M. Clin Oncol (R Coll Radiol), 2013;25(1):66-73

Comparison of setup accuracy and intra-fraction motion using stereotactic frame versus 3-point thermoplastic mask based immobilization for fractionated cranial image-guided radiotherapy.   Rosenfelder NA, Corsini L, McNair H, Pennert K, Aitken A, Lamb CL, Long M, Clarke E, Murcia M, Schick U, Burke K, Ashley S, Khoo V, Brada M. Practical Radiation Oncology, 2013;3:171-179

Brain Metastases. Rosenfelder N, Khoo V. Clin Evid (Online). 2011 Jul 26;2011

Book chapters include:

Nicola Rosenfelder, Fiona Stewart, Michael Brada. Vascular effect of radiation in the central nervous system.  Chapter in Human Radiation Injury. Book Editor(s): Dennis C. Shrieve and Jay S. Loeffler. Published by Lippincott Williams & Wilkins 2011

Radiotherapy in Pituitary Tumours. Rosenfelder N, Solda F, Brada M.  Due be published in DeGroot’s Endocrinology, 8th Edition

She is an Associate Faculty Member at The Institute of Cancer Research, and is a tutor on the ICR's MSc programme, as well as being College Tutor for The Royal Marsden.

Read more
Oncology
Recommended by 1 specialist
29 years of experience
Prostate Cancer, Bladder Cancer, Clinical Oncology

Dr Vinod Mullassery is a consultant clinical oncologist in London who treats prostate and bladder cancers at Guy's and St Thomas' NHS Foundation Trust and the Prostate Centre in Harley Street. He treats patients with radiation, chemotherapy, and hormones. He is also the brachytherapy lead, and he developed the image-guided interstitial brachytherapy programme for cervical cancer.

Dr Mullassery earned his MD in 1999 and went on to undertake oncology training at University College Hospital and Great Ormond Street Hospital. He later undertook a post-CCT fellowship in contemporary radiation therapies at Mount Vernon Cancer Centre. In 2013, he was awarded the American Brachytherapy Society HDR Scholarship Award. He has also been a visiting brachytherapy fellow at the Universities of Leuven, Belgium, and Los Angeles, California.

Dr Mullassery is a dedicated educator who has been a Royal College Tutor as well as the Postgraduate Faculty Lead at Guy's Hospital. In addition, he was the Deputy Firm Head at GKT Medical School. He is also involved in research and now works as the Principal Investigator on many clinical trials. His research interests include the use of novel radiation techniques to treat prostate cancer and oligometastatic disease.

Read more
Oncology
22 years of experience
Bowel Cancer, Breast Cancer, Clinical Oncology + 10 more

Dr Tom Richards, Consultant Clinical Oncologist, currently works within the University College London NHS Hospital (UCLH) NHS Trust and The Whittington NHS Hospital. He also sees patients in several other clinics privately. He is highly experienced in managing and treating gastrointestinal (GI) and breast cancers. In his daily work, he treats cancers of the oesophagus, stomach, liver, pancreaticobiliary, colorectal and breast. He can perform a wide range of procedures including radiotherapy, chemotherapy, and biological targeted drug. He has a special interest in specific radiotherapy techniques including cyberknife, intensity-modulated, 4D-CT planning, deep inspiratory breath-hold, and image-guided radiotherapy.

Dr Richards graduated from Imperial College School of Medicine, before starting his specialist training in general internal medicine at King's College Hospital in London. Following this, he went on to do oncology training in 2015 at St Bartholomew's and The Royal Marsden Hospitals. During his training, he undertook a research degree at The Institute of Cancer Research examining the mechanisms by which therapeutic radiation affects normal tissues and strategies to detect and reduce late toxicity after curative treatment, he was later awarded a PhD for his work. His PhD work was also recognised by the research community as he was awarded the Johnson and Johnson clinical research prize in 2012 for this work. After he completed his training, he was appointed as Clinical Oncology Consultant at St Bartholomew's and The Royal London NHS Hospitals. 

Dr Richards has several professional memberships including The Royal College of Physicians, ESMO, and ESTRO. Additionally, he has been appointed a Fellow of the Royal College of Radiologists. He actively engages with the scientific community, having chaired and spoken at conferences and meetings around the world. He is also an excellent teacher, holding the position of the course tutor and examiner for an MSc course at the Institute of Cancer research and is the local principal investigator for several GI cancer clinical trials.

Read more